Results 131 to 140 of about 17,677 (210)

Artificial intelligence‐based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis

open access: yesEuropean Journal of Heart Failure, EarlyView.
Artificial intelligence (AI)‐based estimation of stroke volume for risk prediction in amyloid transthyretin cardiomyopathy (ATTR‐CM). ATTRv, hereditary transthyretin amyloidosis; ATTRwt, wild‐type transthyretin amyloidosis; CI, confidence interval; HR, hazard ratio; IQR, interquartile range; LVOT‐VTI, left ventricular outflow tract velocity‐time ...
Lucia Venneri   +23 more
wiley   +1 more source

Left ventricular transthyretin amyloid load and apical sparing in patients with newly confirmed transthyretin amyloid cardiomyopathy

open access: yesEuropean Journal of Heart Failure, EarlyView.
In a large cohort of patients with newly diagnosed transthyretin amyloid cardiomyopathy (ATTR‐CM), echocardiographic apical sparing was associated with increased left ventricular amyloid load and atrial remodelling. Quantitative biopsy analysis revealed that Perugini scores often failed to accurately reflect myocardial amyloid burden.
Thomas Krammer   +21 more
wiley   +1 more source

Loop diuretic therapy with or without heart failure: impact on prognosis. [PDF]

open access: yesEur Heart J
Friday JM   +10 more
europepmc   +1 more source

Short‐ and mid‐term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure

open access: yesEuropean Journal of Heart Failure, EarlyView.
Effects of empagliflozin on sodium and fluid regulation in chronic heart failure (CHF). EF, ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide NYHA, New York Heart Association. Aims Sodium–glucose co‐transporter 2 inhibitors have become a cornerstone in managing chronic heart failure (CHF).
Venera Bytyqi   +11 more
wiley   +1 more source

Urinary markers in heart failure – types, timing and thresholds. European Journal of Heart Failure expert consensus document

open access: yesEuropean Journal of Heart Failure, EarlyView.
Pathophysiologic mechanisms of heart failure (HF) (i.e. renin–angiotensin–aldosterone system [RAAS], congestion, and inflammation), together with patient‐related factors such as diabetes, hypertension, and chronic kidney disease (CKD), contribute to kidney function decline and glomerular or tubular injury.
Masatake Kobayashi   +14 more
wiley   +1 more source

Outpatient loop diuretic use and the effect of natriuresis‐guided diuretic therapy: A prespecified sub‐analysis of the PUSH‐AHF study

open access: yesEuropean Journal of Heart Failure, EarlyView.
The effects of natriuresis‐guided diuretic therapy in patients with acute decompensated heart failure, depending on outpatient loop diuretic use. HR, hazard ratio; NG, natriuresis‐guided; SOC, standard of care. Aims Diuretic resistance is frequently observed in patients with acute decompensated heart failure (ADHF), specifically in those with chronic ...
Lara E.E.C. Zonneveld   +10 more
wiley   +1 more source

Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials. [PDF]

open access: yesEur J Heart Fail
Chatur S   +11 more
europepmc   +1 more source

Finerenone in patients with severe heart failure: The FINEARTS‐HF trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
Severe heart failure and treatment with finerenone. CI, confidence interval; CV, cardiovascular; HF, heart failure; LVEF, left ventricular ejection fraction; RR, rate ratio. Aims While patients with severe heart failure (HF) were historically considered to have reduced left ventricular ejection fraction (LVEF), it is increasingly recognized that severe
Riccardo M. Inciardi   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy